USSTOCK.TODAY
Market Closed
Log in Sign up

NovoCure Raises Revenue and Adjusted EBITDA Guidance

Earnings Whispers +1 · ·by G4L

NVCR
NVCR NovoCure Ltd
$11.81 -5.75%
View chart & analysis →
  1. 1NovoCure's revenue of $193.4 million exceeded the expected $183.32 million by 5.5%.
  2. 2Management raised the 2026 annual revenue guidance from $736 million to $743 million.
  3. 3Management raised the adjusted EBITDA guidance from $24 million to $34 million.

So what's the key point?

NovoCure earned more revenue than experts expected. The company also raised its future earnings outlook.

Source Earnings Whispers +1 · View original ↗

Related 3-line summaries

EQT raises production outlook, trims capex guidance Proactive +13 · Jul 24Tom Lee: Clarity Act passage odds are underestimated by prediction markets CCN +2 · Jul 24JPMorgan Overweights Palantir Technologies and Sets Price Target Investing.com · Oct 29
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news